Abacavir, an anti–HIV-1 drug, targets TDP1-deficient adult T cell leukemia-Reference-Cited by-同舟云学术

Abacavir, an anti–HIV-1 drug, targets TDP1-deficient adult T cell leukemia

Published:2015-04-03 Issue:3 Volume:1 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Tada Kohei¹,Kobayashi Masayuki¹^ORCID,Takiuchi Yoko¹,Iwai Fumie¹,Sakamoto Takashi¹,Nagata Kayoko¹,Shinohara Masanobu¹,Io Katsuhiro¹,Shirakawa Kotaro¹,Hishizawa Masakatsu¹,Shindo Keisuke¹,Kadowaki Norimitsu¹,Hirota Kouji²,Yamamoto Junpei³,Iwai Shigenori³,Sasanuma Hiroyuki⁴,Takeda Shunichi⁴,Takaori-Kondo Akifumi¹

Affiliation:

1. Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin-kawaracho, Sakyo-ku, Kyoto 606-8507, Japan.

2. Department of Chemistry, Graduate School of Science and Engineering, Tokyo Metropolitan University, 1-1 Minami-Osawa, Hachioji-shi, Tokyo 192-0397, Japan.

3. Division of Chemistry, Graduate School of Engineering Science, Osaka University, 1-3 Machikaneyama, Toyonaka, Osaka 560-8531, Japan.

4. Department of Radiation Genetics, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.

Abstract

An anti–HIV-1 drug is found to destroy leukemia cells in adults.

Funder

the Ministry of Health, Labour and Welfare of Japan

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference84 articles.

1. Adult T-cell leukemia: Clinical and hematologic features of 16 cases;Uchiyama T.;Blood,1977